BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/30/2021 7:03:44 AM | Browse: 571 | Download: 1109
 |
Received |
|
2021-01-18 10:04 |
|
Peer-Review Started |
|
2021-01-18 10:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-09 21:07 |
|
Revised |
|
2021-02-17 07:03 |
|
Second Decision |
|
2021-03-19 11:21 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-03-19 14:51 |
|
Articles in Press |
|
2021-03-19 14:51 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-03-23 14:35 |
|
Typeset the Manuscript |
|
2021-03-26 07:55 |
|
Publish the Manuscript Online |
|
2021-03-30 07:03 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
COVID-19 and co-morbidities of hepatic diseases in a global perspective
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Aqsa Ahmad, Syeda Momna Ishtiaq, Junaid Ali Khan, Rizwan Aslam, Sultan Ali and Muhammad Imran Arshad |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Muhammad Imran Arshad, PhD, Assistant Professor, Institute of Microbiology, University of Agriculture Faisalabad, Main Agriculture University and Jail Road, Faisalabad 38040, Punjab, Pakistan. drimranarshad@yahoo.com |
| Key Words |
Liver diseases; COVID-19; Pathophysiology; Epidemiology; Prophylaxis |
| Core Tip |
The clinical menace of coronavirus disease 2019 (COVID-19)-related co-morbidities of hepatic diseases and severe acute respiratory syndrome-coronavirus type 2 (SARS-CoV-2) tropism for liver have resulted in liver impairment with increased liver injury markers and cytokine storm. The SARS-CoV-2 aggravates liver injury via coagulative and fibrinolytic pathways, cytokine mediated liver injury, ischemia-hypoxia and immune mediated cell death pathways owing to adverse outcome of liver diseases such as non-alcoholic steatohepatitis, drug-induced liver injuries, non-alcoholic fatty liver disease, metabolic associated fatty liver disease and hepatocellular carcinoma. This review presented diagnostic approaches, therapeutics, clinical guidelines and vaccines for COVID-19 and co-morbidities of liver diseases. |
| Publish Date |
2021-03-30 07:03 |
| Citation |
Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and co-morbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i13/1296.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i13.1296 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
